Virtus LifeSci Biotech Products ETF Rating $64.26 +0.18 (+0.28%) (As of 07/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy2.78Holdings in BBP have an aggregate rating of Moderate Buy based on 588 analyst ratings issued in the past year covering 50 companies (83.3% of the portfolio).BBP Aggregate Price Target$94.5647.15% UpsideHigh Prediction$153.96Average Prediction$94.56Low Prediction$64.64Holdings in BBP have an aggregate price target of $94.56 and a range of $64.64 to $153.96 covering 50 companies (83.3% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy32 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.24%ALNYAlnylam Pharmaceuticals$234.84-1.3%3.3781 of 5 stars3.38 / 5 stars2.67$256.73 9.3%24Upcoming EarningsShort Interest ↑2.24%MIRMMirum Pharmaceuticals$43.33+7.3%3.8403 of 5 stars3.84 / 5 stars3.17$53.64 23.8%12Upcoming EarningsAnalyst ForecastNews CoverageHigh Trading Volume2.04%TVTXTravere Therapeutics$9.89+1.2%1.3033 of 5 stars1.30 / 5 stars2.58$14.64 48.0%12Upcoming EarningsNews Coverage2.03%LEGNLegend Biotech$56.61-4.3%3.1141 of 5 stars3.11 / 5 stars3.00$81.31 43.6%141.89%TGTXTG Therapeutics$20.57+3.0%4.0646 of 5 stars4.06 / 5 stars2.83$29.83 45.1%61.87%ADMAADMA Biologics$13.16+0.6%1.6464 of 5 stars1.65 / 5 stars3.25$12.25 -6.9%4Short Interest ↑1.86%INSMInsmed$74.54+0.1%3.1607 of 5 stars3.16 / 5 stars3.00$74.50 -0.1%16Upcoming EarningsShort Interest ↑1.85%LGNDLigand Pharmaceuticals$107.14+1.1%4.4443 of 5 stars4.44 / 5 stars3.00$126.33 17.9%3Short Interest ↑1.78%ACADACADIA Pharmaceuticals$19.14+3.2%4.2519 of 5 stars4.25 / 5 stars2.76$28.59 49.4%17Short Interest ↓Analyst RevisionNews Coverage1.77%AXSMAxsome Therapeutics$86.53+0.6%4.6877 of 5 stars4.69 / 5 stars2.93$123.85 43.1%14Analyst ForecastAnalyst Revision1.76%SRPTSarepta Therapeutics$144.24-2.2%4.9099 of 5 stars4.91 / 5 stars2.78$187.72 30.1%18Short Interest ↓1.76%IONSIonis Pharmaceuticals$51.45-0.8%3.8922 of 5 stars3.89 / 5 stars2.79$60.18 17.0%19Upcoming EarningsAnalyst ForecastAnalyst Revision1.75%DAWNDay One Biopharmaceuticals$16.03+0.9%2.1587 of 5 stars2.16 / 5 stars2.86$37.67 135.0%7Analyst ForecastShort Interest ↑News Coverage1.73%UTHRUnited Therapeutics$338.22+0.5%4.6416 of 5 stars4.64 / 5 stars2.83$330.64 -2.2%12Upcoming EarningsAnalyst ForecastInsider SellingAnalyst RevisionNews Coverage1.73%BCRXBioCryst Pharmaceuticals$7.85+4.0%4.1374 of 5 stars4.14 / 5 stars3.00$14.67 86.8%6Short Interest ↑1.72%GILDGilead Sciences$77.01+0.7%4.793 of 5 stars4.79 / 5 stars2.33$81.81 6.2%18Options VolumeAnalyst Revision1.71%KNSAKiniksa Pharmaceuticals$26.12+0.8%2.1827 of 5 stars2.18 / 5 stars3.00$32.00 22.5%4Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓Analyst RevisionNews Coverage1.70%IRWDIronwood Pharmaceuticals$7.04+3.7%4.5469 of 5 stars4.55 / 5 stars3.00$18.40 161.4%5Positive NewsGap Down1.69%RYTMRhythm Pharmaceuticals$49.05-1.1%2.3962 of 5 stars2.40 / 5 stars2.83$55.83 13.8%6Analyst ForecastNews Coverage1.68%TBPHTheravance Biopharma$10.25+0.4%2.197 of 5 stars2.20 / 5 stars3.00$20.50 100.0%2Analyst DowngradeNews Coverage1.68%AMGNAmgen$334.85+0.2%4.4956 of 5 stars4.50 / 5 stars2.52$312.63 -6.6%21Short Interest ↑Analyst Revision1.68%KRYSKrystal Biotech$213.66+1.4%4.193 of 5 stars4.19 / 5 stars3.00$177.63 -16.9%9Positive News1.65%ITCIIntra-Cellular Therapies$80.39-0.6%4.6796 of 5 stars4.68 / 5 stars2.83$94.83 18.0%12Short Interest ↓News Coverage1.64%LXRXLexicon Pharmaceuticals$2.39+2.6%1.7872 of 5 stars1.79 / 5 stars2.75$6.67 178.9%4Upcoming EarningsNews CoverageGap Up1.64%HALOHalozyme Therapeutics$56.23+0.5%4.8082 of 5 stars4.81 / 5 stars2.75$58.38 3.8%8Insider Selling1.63%HRMYHarmony Biosciences$33.92+1.9%3.6871 of 5 stars3.69 / 5 stars2.56$41.67 22.8%9Analyst Revision1.63%BPMCBlueprint Medicines$112.19-1.3%0.598 of 5 stars0.60 / 5 stars2.63$116.33 3.7%16Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage1.61%SAGESage Therapeutics$10.99+5.0%4.3156 of 5 stars4.32 / 5 stars2.00$33.55 205.3%20Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageGap Down1.61%NBIXNeurocrine Biosciences$146.80+0.5%4.7048 of 5 stars4.70 / 5 stars2.78$154.08 5.0%23Upcoming EarningsAnalyst ForecastNews Coverage1.60%ASNDAscendis Pharma A/S$133.75-0.5%3.4624 of 5 stars3.46 / 5 stars2.90$179.00 33.8%10Analyst RevisionNews CoveragePositive News1.59%INCYIncyte$68.61+0.1%4.6793 of 5 stars4.68 / 5 stars2.39$73.25 6.8%18Upcoming EarningsAnalyst ForecastNews Coverage1.57%MDGLMadrigal Pharmaceuticals$284.49+0.4%4.2391 of 5 stars4.24 / 5 stars2.69$348.50 22.5%13Analyst Forecast1.57%REGNRegeneron Pharmaceuticals$1,078.63+1.4%4.2399 of 5 stars4.24 / 5 stars2.78$1,074.95 -0.3%23Upcoming EarningsAnalyst ForecastAnalyst Revision1.57%AUPHAurinia Pharmaceuticals$5.68+1.4%2.6055 of 5 stars2.61 / 5 stars2.75$10.00 76.1%4Upcoming EarningsShort Interest ↓1.55%EXELExelixis$23.39+1.9%4.8413 of 5 stars4.84 / 5 stars2.59$26.13 11.7%17Analyst RevisionNews Coverage1.55%VRTXVertex Pharmaceuticals$495.26+0.6%3.9637 of 5 stars3.96 / 5 stars2.54$460.30 -7.1%26Upcoming EarningsAnalyst ForecastInsider SellingNews Coverage1.54%ROIVRoivant Sciences$10.80+0.6%3.0371 of 5 stars3.04 / 5 stars2.90$17.10 58.3%101.51%AGIOAgios Pharmaceuticals$48.05-0.9%1.298 of 5 stars1.30 / 5 stars2.50$50.67 5.4%4Upcoming EarningsAnalyst RevisionNews Coverage1.51%BMRNBioMarin Pharmaceutical$84.59-1.2%4.8983 of 5 stars4.90 / 5 stars2.55$102.00 20.6%20Analyst ForecastShort Interest ↓Analyst RevisionNews Coverage1.51%IMCRImmunocore$40.130.0%2.5694 of 5 stars2.57 / 5 stars2.93$82.75 106.2%14Positive News1.51%PHATPhathom Pharmaceuticals$11.74+4.1%2.6863 of 5 stars2.69 / 5 stars2.75$22.00 87.4%4Analyst ForecastNews Coverage1.49%RAREUltragenyx Pharmaceutical$44.86-0.4%4.3738 of 5 stars4.37 / 5 stars2.93$86.50 92.8%14Upcoming EarningsAnalyst Forecast1.49%IBRXImmunityBio$5.61+2.2%0.2689 of 5 stars0.27 / 5 stars2.00$6.00 7.0%1Gap Up1.47%FOLDAmicus Therapeutics$10.18-0.8%4.1696 of 5 stars4.17 / 5 stars2.88$17.57 72.6%8News CoveragePositive News1.46%BIIBBiogen$211.17-7.2%4.8342 of 5 stars4.83 / 5 stars2.65$286.00 35.4%26Upcoming EarningsAnalyst ForecastShort Interest ↑Gap Down1.46%SWTXSpringWorks Therapeutics$38.04+3.2%1.3091 of 5 stars1.31 / 5 stars3.00$68.83 80.9%6News Coverage1.45%YMABY-mAbs Therapeutics$12.53+1.6%2.2247 of 5 stars2.22 / 5 stars2.43$17.86 42.5%7Short Interest ↑Positive News1.43%ZLABZai Lab$18.86-0.1%2.382 of 5 stars2.38 / 5 stars3.00$58.97 212.7%51.43%IOVAIovance Biotherapeutics$9.25-1.9%3.7328 of 5 stars3.73 / 5 stars3.00$24.45 164.4%10Gap Up1.42%GERNGeron$4.66+8.6%4.3574 of 5 stars4.36 / 5 stars2.86$6.93 48.7%7Analyst ForecastNews Coverage This page (NYSEARCA:BBP) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
